4th Quarter - Report

THE MCMANUS GROUP for ANTIMICROBIAL INNOVATION ALLIANCE

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

H.R.2029 - Consolidated Appropriations Act, 2016.

LobbyistCovered position, as disclosed
JOHN MCMANUS —
CHASE M THOMAS —
BARRETT THORNHILL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2029 (114th)

Health Issues HCR

Development of policies to advance the antimicrobial research and development environment. Support of H.R. 512 - DISARM Act of 2015 language in H.R. 6 - The 21st Century Cures Act. Antibiotic policy regarding Innovation for Healthier Americans Report.

LobbyistCovered position, as disclosed
JOHN MCMANUS —
CHASE M THOMAS —
BARRETT THORNHILL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 512 (114th), H.R. 6 (114th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.